title: Economic Impact of the Use of an Absorbable Adhesion Barrier in Preventing Adhesions Following Open Gynecologic Surgeries.
abstract: We used an economic model to assess the impact of using the GYNECARE INTERCEED absorbable adhesion barrier for reducing the incidence of postoperative adhesions in open surgical gynecologic procedures. Caesarean section surgery, hysterectomy, myomectomy, ovarian surgery, tubal surgery, and endometriosis surgery were modeled with and without the use of GYNECARE INTERCEED absorbable adhesion barrier. Incremental GYNECARE INTERCEED absorbable adhesion barrier material costs, medical costs arising from complications, and adhesion-related readmissions were considered. GYNECARE INTERCEED absorbable adhesion barrier use was assumed in 75% of all procedures. The economic impact was reported during a 3-year period from a United States hospital perspective. Assuming 100 gynecologic surgeries of each type and an average of one GYNECARE INTERCEED absorbable adhesion barrier sheet per surgery, a net savings of $540,823 with GYNECARE INTERCEED absorbable adhesion barrier during 3 years is estimated. In addition, GYNECARE INTERCEED absorbable adhesion barrier use resulted in 62 fewer cases of patients developing adhesions. Although the use of GYNECARE INTERCEED absorbable adhesion barrier added $137,250 in material costs, this was completely offset by the reduction in length of stay ($178,766 savings), fewer adhesion-related readmissions ($458,220 savings), and operating room cost ($41,078 savings). Adoption of the GYNECARE INTERCEED absorbable adhesion barrier for appropriate gynecologic surgeries would likely result in significant savings for hospitals, driven primarily by clinical patient benefits in terms of decreased length of stay and adhesion-related readmissions.
authors.affiliation: Ethicon (Johnson & Johnson), Somerville, New Jersey 08876.
authors.forename: Sanjoy
authors.initials: S
authors.lastname: Roy
authors.affiliation: Xcenda, Palm Harbor, Florida 34685.
authors.forename: Rashad
authors.initials: R
authors.lastname: Carlton
authors.affiliation: Ethicon (Johnson & Johnson), Somerville, New Jersey 08876.
authors.forename: Martin
authors.initials: M
authors.lastname: Weisberg
authors.affiliation: Xcenda, Palm Harbor, Florida 34685.
authors.forename: Ryan
authors.initials: R
authors.lastname: Clark
authors.affiliation: Xcenda, 4114 Woodlands Pkwy, Palm Harbor, FL 34685.
authors.forename: Kristen
authors.initials: K
authors.lastname: Migliaccio-Walle
authors.affiliation: Women's Specialty Center and Department of Obstetrics and Gynecology, Methodist Medical Center, Dallas, Texas 75203.
authors.forename: Hector
authors.initials: H
authors.lastname: Chapa
mesh_terms: D020341:Absorbable Implants / Q000191:economics*; D002483:Cellulose, Oxidized / Q000191:economics* / Q000627:therapeutic use; D005260:Female; D013509:Gynecologic Surgical Procedures / Q000009:adverse effects*; D006801:Humans; D007902:Length of Stay / Q000191:economics; D018803:Models, Economic; D009873:Operating Rooms / Q000191:economics; D010359:Patient Readmission / Q000191:economics; D000267:Tissue Adhesions / Q000191:economics* / Q000209:etiology / Q000517:prevention & control*; D014481:United States
chemical_list: D002483:Cellulose, Oxidized; C060002:INTERCEED